| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $57.6M | +13.8% |
| Cost of Revenue | $17.9M | -14.2% |
| R&D Expense | $20.3M | +54.8% |
| SG&A Expense | $50.2M | +58.0% |
| Operating Income | -$30.8M | -103.8% |
| Pre-tax Income | -$44.2M | -479.0% |
| Income Tax | -$14K | -105.7% |
| Net Income | -$44.1M | -460.8% |
| EPS (Basic) | -$0.51 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $7.3M | -13.3% |
| Inventory | $6.0M | -10.7% |
| Current Assets | $88.2M | +115.3% |
| Total Assets | $101.4M | +76.6% |
| Current Liabilities | $18.9M | +3.0% |
| Long-term Debt | $45.0M | +0.0% |
| Total Liabilities | $161.6M | -1.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.8M | -460.5% |
| Capital Expenditures | $159K | -84.0% |
| Investing Cash Flow | -$159K | +84.0% |
| Financing Cash Flow | $83.6M | +2003.5% |
| Free Cash Flow | -$35.9M | -387.0% |
| -292.3% |
| EPS (Diluted) | -$0.51 | -292.3% |
| Stockholders' Equity |
| -$60.2M |
| +43.5% |